Maged Shenouda is CFO at RELMADA THERAPEUTICS, INC. (RLMD). They have made 17 open-market trades across 2 companies since 2015, most recently 2026-09-10.
CIK 0001658369
10 open-market purchases totalling $2.5M since 2015, against 7 sales. Across 9 scored buys the stock is up 11.4% at ninety days, and 5.9 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RLMD | 1,000,000 | $3.1M |
| AZRX | 62,500 | $216K |
| PRGB | 100,000 | — |
| Total | $3.3M |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 60% | 78% |
| Avg Move | +51.1% | +13.4% | +11.4% |
| Alpha | +39.9% | +11.6% | +5.9% |
| Scored | 10 | 10 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLMD | BUY | 2026-09-09 | 2026-09-11 | $4.22 | $844K | -16.7% | -22.4% | — |
| RLMD | BUY | 2025-12-15 | 2025-12-16 | $4.12 | $48K | -2.4% | -16.7% | +35.3% |
| RLMD | BUY | 2025-11-05 | 2025-11-06 | $2.20 | $1.1M | +64.2% | +60.4% | +40.4% |
| RLMD | BUY | 2025-05-16 | 2025-05-20 | $0.49 | $97K | +9.0% | +4.4% | +2.2% |
| RLMD | BUY | 2024-09-09 | 2024-09-11 | $2.78 | $207K | -0.6% | -6.0% | -86.7% |
| RLMD | BUY | 2024-01-29 | 2024-01-31 | $3.85 | $126K | +26.6% | +56.0% | -16.5% |
| RLMD | SELL | 2021-03-08 | 2021-03-10 | $35.45 | $706K | +1.8% | +0.9% | -13.1% |
| RLMD | SELL | 2021-02-24 | 2021-02-26 | $34.17 | $103K | +3.0% | -3.5% | +7.3% |
| RLMD | SELL | 2021-02-11 | 2021-02-16 | $35.39 | $101K | -12.1% | -6.4% | -7.9% |
| RLMD | SELL | 2021-02-08 | 2021-02-10 | $35.16 | $715K | +0.9% | +4.9% | -0.1% |
| RLMD | SELL | 2021-02-02 | 2021-02-04 | $35.04 | $112K | +6.2% | +0.3% | +9.6% |
| RLMD | SELL | 2021-01-27 | 2021-01-29 | $31.93 | $96K | +6.9% | +3.1% | +18.8% |
| RLMD | SELL | 2021-01-22 | 2021-01-26 | $35.41 | $202K | -0.5% | -0.5% | +9.8% |
| RLMD | BUY | 2019-10-21 | 2019-10-21 | $23.00 | $22K | -3.4% | -4.4% | +38.9% |
| AZRX | BUY | 2018-12-28 | 2019-01-02 | $1.31 | $26K | +70.5% | +56.8% | +83.5% |
| RLMD | BUY | 2015-12-15 | 2015-12-17 | $2.99 | $9K | +181.7% | +2.9% | +2.9% |
| RLMD | BUY | 2015-12-14 | 2015-12-16 | $2.89 | $6K | +181.7% | +2.9% | +2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.